Study of vitamin B12 deficiency in chronic kidney disease


  • Vinod Ananda Dandge Department of Medicine, Surat Institute of Medical College and Research, Surat, Gujarat, India
  • Dhruv Variya Department of Medicine, Surat Institute of Medical College and Research, Surat, Gujarat, India



Chronic kidney disease, Erythropoietin, Serum vitamin B12, Uraemia


Background: Chronic Kidney Disease (CKD) is a growing health burden and important cause of morality and morbidity worldwide as well as India. Anaemia a feature of CKD, is multifactorial, one of the most important factor responsible for the development of left ventricular hypertrophy, diastolic and later systolic dysfunction and cardiovascular disease, which is the single most important contributor to the mortality in CKD. Severe Chronic Kidney Disease has an adverse effect on haematopoiesisis. Lack of erythropoietin, Iron deficiency anaemia and shortened red cell life span, Nutritional deficiency or deranged metabolism of vitamins is the major factors contributing to anaemia in CRF. Patients with CKD show megaloblastosis on examination of the bone marrow. Suggestive of Vitamin B12 and folic acid deficiency might Be Additional Factors Contributing to inadequate Haematopoiesis in uremia. Patients with CKD are at higher risk for nutritional deficiencies due to medication interactions, dietary restrictions and malnutrition. The dialysis procedure itself may cause loss of vitamin B12, Folic acid and there deficiency.

Methods: Sample size of 80 cases of CKD patients aged between 18-80 year admitted in SMIMER Hospital were included in study. Serum vitamin B12 Level was checked, correlation B12 deficiency with duration of CKD was observed.

Results: It was observed that, 47 cases of CKD had vitamin B12 deficiency. The mean duration of CKD is more in B12deficient group as compared to Normal Group and also finds the higher proportion of vitamin B12 deficiency in CKD patients.

Conclusions: Serum vitamin B12 level testing should be recommended routinely in patients with CKD and All the treating Nephrologists should anticipate the deficiency of vitamin B12 in CKD patients.


Marti F, Vollenweider P, Marques-Vidal PM, Mooser V, Waeber G, Paccaud F, et al. Hyperhomocysteinemia is independently associated with albuminuria in the population-based CoLaus study. BMC Public Health. 2011Dec;11(1):733.

Soohoo M, Ahmadi SF, Qader H, Streja E, Obi Y, Moradi H, et al. Association of serum vitaminB12 and folate with mortality in incident haemodialysis patients. Nephrol Dialysis Transplanta. 2016May11;32(6):1024-32.

Ankar A, Kumar A. Vitamin B12 Deficiency (Cobalamin). Stat Pearls. 2019;2019.

Brattström L, Wilcken DE. Homocysteine and cardiovascular disease: cause or effect?. The Am J Clini Nutr. 2000 Aug 1;72(2):315-23.

Ermens AA, Vlasveld LT, Lindemans J. Significance of elevated cobalamin (vitamin B12) levels in blood. Clini Biochem. 2003 Nov 1;36(8):585-90.

Andrès E, Serraj K, Zhu J, Vermorken AJ. The pathophysiology of elevated vitamin B12 in clinical practice. QJM: Inter J Med. 2013 Jun 1;106(6):505-15.

Sviri S, Khalaila R, Daher S, Bayya A, Linton DM, Stav I, et al. Increased Vitamin B12 levels are associated with mortality in critically ill medical patients. Clini Nutr. 2012 Feb 1;31(1):53-9.

Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: the Third National Health and Nutrition Examination Survey (1988-1994). Arch Int Med. 2002 Jun 24;162(12):1401-8.

McMahon GM, Hwang SJ, Fox CS. The association between vitamin B12, albuminuria and reduced kidney function: an observational cohort study. BMC Nephrol. 2015 Feb 2;16:7.

Babazono T, Hanai K, Suzuki K, Kiuchi Y, Inoue A, Tanaka M, Tanaka N, Hase M, Ishii A, Iwamoto Y. Lower haemoglobin level and subsequent decline in kidney function in type 2 diabetic adults without clinical albuminuria. Diabetologia. 2006 Jun 1;49(6):1387-93.

Thomas MC, MacIsaac RJ, Tsalamandris C, Power D, Jerums G. Unrecognized anemia in patients with diabetes: a cross-sectional survey. Diabetes Care. 2003 Apr 1;26(4):1164-9.

Levey AS, De Jong PE, Coresh J, Nahas ME, Astor BC, Matsushita K, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Inter. 2011 Jul 1;80(1):17-28.

Astor BC, Arnett DK, Brown A, Coresh J. Association of kidney function and haemoglobin with left ventricular morphology among African Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am J Kidney Dis. 2004;43:836.

Ulasi II, Arodiwe EB, Ijoma CK. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation. Ethni Dis. 2006 Sep 1;16(4):859-64.

Qin X, Huo Y, Langman CB, Hou F, Chen Y, Matossian D, Xu X, Wang X. Folic acid therapy and cardiovascular disease in ESRD or advanced chronic kidney disease: a meta-analysis. Clini J Am Soc Nephrol. 2011 Mar 1;6(3):482-8.

Geneva S. Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity. 2011 Vitamin and Mineral Nutrition Information System. Available at: http://www. who. int/entity/vmnis/indicators/haemoglobin. pdf Accessed on 6 February 2017.






Original Research Articles